- Home
- CVEO vs ALDX Comparison
CVEO vs ALDX Comparison
Compare CVEO & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVEO
- ALDX
- Stock Information
- Founded
- CVEO 1977
- ALDX 2004
- Country
- CVEO United States
- ALDX United States
- Employees
- CVEO N/A
- ALDX N/A
- Industry
- CVEO Hotels/Resorts
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- CVEO Consumer Discretionary
- ALDX Health Care
- Exchange
- CVEO Nasdaq
- ALDX Nasdaq
- Market Cap
- CVEO 284.2M
- ALDX 296.0M
- IPO Year
- CVEO N/A
- ALDX 2014
- Fundamental
- Price
- CVEO $22.15
- ALDX $4.65
- Analyst Decision
- CVEO Strong Buy
- ALDX Strong Buy
- Analyst Count
- CVEO 1
- ALDX 2
- Target Price
- CVEO $27.00
- ALDX $9.50
- AVG Volume (30 Days)
- CVEO 90.3K
- ALDX 612.2K
- Earning Date
- CVEO 10-31-2025
- ALDX 11-06-2025
- Dividend Yield
- CVEO 2.25%
- ALDX N/A
- EPS Growth
- CVEO N/A
- ALDX N/A
- EPS
- CVEO N/A
- ALDX N/A
- Revenue
- CVEO $628,180,000.00
- ALDX N/A
- Revenue This Year
- CVEO N/A
- ALDX N/A
- Revenue Next Year
- CVEO $2.62
- ALDX $63.48
- P/E Ratio
- CVEO N/A
- ALDX N/A
- Revenue Growth
- CVEO N/A
- ALDX N/A
- 52 Week Low
- CVEO $18.01
- ALDX $1.14
- 52 Week High
- CVEO $27.55
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- CVEO 48.53
- ALDX 34.50
- Support Level
- CVEO $21.15
- ALDX $4.85
- Resistance Level
- CVEO $22.33
- ALDX $5.27
- Average True Range (ATR)
- CVEO 0.84
- ALDX 0.27
- MACD
- CVEO -0.00
- ALDX -0.06
- Stochastic Oscillator
- CVEO 49.41
- ALDX 12.20
About CVEO Civeo Corporation (Canada)
Civeo Corp provides hospitality services to the natural resources industry in Canada, Australia and the United States. The company provides a full suite of services for guests, including lodging, catering and food service, housekeeping and maintenance at accommodation facilities that the company or its customers own. The company provides services that support the day-to-day operations of these facilities, such as laundry, facility management and maintenance, water and wastewater treatments, power generation, communication systems, security and logistics. The company operates in active oil, metallurgical coal, liquefied natural gas and iron ore-producing regions. The company operates in three reportable business segments Canada, Australia and the United States.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.